当前位置: 首页 >> 检索结果
共有 130969 条符合本次的查询结果, 用时 4.7873108 秒

741. Appendicectomy in children with uncomplicated appendicitis.

作者: Dimitrios Moris.;Diamantis Tsilimigras.;Theodore Pappas.
来源: Lancet. 2025年406卷10508期1086-1087页

742. Haemodiafiltration versus haemodialysis for kidney failure.

作者: Fergus J Caskey.;Albert Power.;Ken Farrington.;Stephanie J MacNeill.;J Athene Lane.
来源: Lancet. 2025年406卷10508期1085页

743. Haemodiafiltration versus haemodialysis for kidney failure - Authors' reply.

作者: Robin Vernooij.;Michiel L Bots.;Mark Woodward.;Peter J Blankestijn.; .
来源: Lancet. 2025年406卷10508期1085-1086页

744. Offline: The unavoidable reckoning.

作者: Richard Horton.
来源: Lancet. 2025年406卷10508期1073页

745. Estimating trends in non-communicable disease mortality: implications for global health data and policy research.

作者: Zachary J Ward.
来源: Lancet. 2025年406卷10509期1195-1197页

746. Benchmarking progress in non-communicable diseases: a global analysis of cause-specific mortality from 2001 to 2019.

作者: .
来源: Lancet. 2025年406卷10509期1255-1282页
Non-communicable diseases (NCDs) have received substantial policy attention globally and in most countries. Our aim was to quantify how much NCD mortality changed from 2010 to 2019 in different countries, especially compared with the preceding decade and with the best-performing country in each region, and the specific NCD causes of death that contributed to change.

747. Parent-focused behavioural interventions for the prevention of early childhood obesity (TOPCHILD): a systematic review and individual participant data meta-analysis.

作者: Kylie E Hunter.;David Nguyen.;Sol Libesman.;Jonathan G Williams.;Mason Aberoumand.;Jannik Aagerup.;Brittany J Johnson.;Rebecca K Golley.;Angie Barba.;James X Sotiropoulos.;Nipun Shrestha.;Talia Palacios.;Samantha J Pryde.;Luke Wolfenden.;Rachael W Taylor.;Peter J Godolphin.;Karen Matvienko-Sikar.;Lee M Sanders.;Kristy P Robledo.;Vicki Brown.;Charles T Wood.;Sarah Taki.;H Shonna Yin.;Alison J Hayes.;Denise A O'Connor.;Wendy Smith.;David E Espinoza.;Lisa Askie.;Paul M Chadwick.;Chris Rissel.;Angela C Webster.;Kylie D Hesketh.;Maria Bryant.;Jessica L Thomson.;Rajalakshmi Lakshman.;Alexander G Fiks.;Christine Helle.;Cathleen Odar Stough.;Ken K Ong.;Eliana M Perrin.;Levie Karssen.;Junilla K Larsen.;Ana M Linares.;Mary Jo Messito.;Li Ming Wen.;Emily Oken.;Nina Cecilie Øverby.;Cristina Palacios.;Ian M Paul.;Finn E Rasmussen.;Elizabeth A Reifsnider.;Russell L Rothman.;Rebecca A Byrne.;Tiffany M Rybak.;Sarah-Jeanne Salvy.;Heather M Wasser.;Amanda L Thompson.;Ata Ghaderi.;Barry J Taylor.;Claudio Maffeis.;Huilan Xu.;Jennifer S Savage.;Kaumudi J Joshipura.;Kayla de la Haye.;Margrethe Røed.;Bethan Copsey.;Natalia Golova.;Rachel S Gross.;Stephanie Anzman-Frasca.;Jinan Banna.;Louise A Baur.;Anna Lene Seidler.; .
来源: Lancet. 2025年406卷10509期1235-1254页
Childhood obesity is a global public health issue, which has prompted governments to invest in prevention programmes. We aimed to investigate the effectiveness of parent-focused early childhood obesity prevention interventions globally.

748. Large-vessel vasculitis.

作者: Patrice Cacoub.;Matheus Vieira.;Carol A Langford.;Zoubida Tazi Mezalek.;David Saadoun.
来源: Lancet. 2025年406卷10514期2017-2032页
Primary large-vessel vasculitis encompasses conditions that, despite sharing many common features, constitute distinct entities that have their own prognostic implications. These conditions include giant cell arteritis and Takayasu arteritis, with isolated aortitis being increasingly recognised in the literature and studied within this disease spectrum. Epidemiological studies have evidenced a worldwide distribution of Takayasu arteritis. In giant cell arteritis, distinct clinical phenotypes with specific outcomes (ie, cranial and large vessel forms) have been recognised. The advancements that have been made in vascular imaging have enabled improvement in diagnosis and classification of these diseases, although their value in follow-up continues to be assessed. Targeted therapies that can induce clinical remission with reduced glucocorticoid exposure are emerging. However, many patients develop vascular damage over time, highlighting the need for further understanding of the pathophysiological link between inflammation, vascular injury, and remodelling.

749. The IASLC-Lancet Commission: a transformative global approach to lung cancer.

作者: C S Pramesh.;Karen Kelly.;David J Hunter.;Vania Coelho Wisdom.
来源: Lancet. 2025年406卷10511期1450-1452页

750. Public views on xenotransplantation from the first representative sample survey in the UK.

作者: Mustafa Al-Haboubi.;Paul Boadu.;Agata Pacho.;Antonia J Cronin.;Nicholas Mays.
来源: Lancet. 2025年406卷10508期1083-1085页

751. Shigellosis.

作者: Jennifer Hendrick.;Rubhana Raqib.;Zannatun Noor.;A S G Faruque.;Rashidul Haque.;William A Petri.
来源: Lancet. 2025年406卷10511期1508-1519页
Shigella is a Gram-negative, facultative intracellular, gastric acid-resistant bacterium of the Enterobacteriaceae family, which includes four serogroups: Shigella dysenteriae, Shigella sonnei, Shigella flexneri, and Shigella boydii. Globally, shigellosis is the most common cause of invasive bloody diarrhoea in children younger than 5 years. Humans are the only natural reservoir and an inoculum of only 10-100 organisms is required for infection. Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease. The prevention of infection with vaccination and sanitation strategies remains a crucial step in reducing worldwide morbidity and mortality.

752. Stop the starvation: restore civilian aid and protect health care in Gaza.

作者: Paul B Spiegel.;Orit Abrahim.;Aula Abbara.;Awsan Bahattab.;Karl Blanchet.
来源: Lancet. 2025年406卷10508期1066-1068页

753. David Nunes Nabarro.

作者: Jacqui Thornton.
来源: Lancet. 2025年406卷10507期1000页

754. John Middleton: a prescription for the blues.

作者: Niall Boyce.
来源: Lancet. 2025年406卷10507期995页

755. Offline: Help us, please.

作者: Richard Horton.
来源: Lancet. 2025年406卷10507期990页

756. The nuclear threat: policy, science, and public opinion.

作者: The Lancet.
来源: Lancet. 2025年406卷10507期979页

757. Social prescribing in Brazil: a path walked, a future to be shaped.

作者: Sandro R R Batista.
来源: Lancet. 2025年406卷10507期1008页

759. The growing evidence base for social prescribing.

作者: Kamila Hawthorne.;Charlotte Osborn-Forde.
来源: Lancet. 2025年406卷10507期1007页

760. Social prescribing in culturally and linguistically diverse populations.

作者: Sabuj Kanti Mistry.;Gulsah Kurt.;Alayne M Adams.;Saruna Ghimire.;Uday Narayan Yadav.
来源: Lancet. 2025年406卷10507期1007-1008页
共有 130969 条符合本次的查询结果, 用时 4.7873108 秒